“All-inside” meniscal repair system provides a high success rate at long-term follow-up

FHS
June 22, 2023
3:02 am

A second-generation “all-inside” meniscal repair system provides a high success rate at long-term follow-up, reports a study in The Journal of Bone & Joint Surgery.

Pharmalittle: We’re reading about Wegovy insurance coverage, Zepbound shortages, and more

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal

March 29, 2024

23ME610 by 23AndMe Holding for Merkel Cell Carcinoma: Likelihood of Approval

23ME610 is under clinical development by 23andMe Holding and currently in Phase II for Merkel Cell Carcinoma.

February 22, 2024

FDA approves AbbVie’s 24-hour Parkinson’s infusion therapy after two CRLs

The FDA has finally approved AbbVie’s infused Parkinson’s drug for patients who don’t respond to widely used oral therapies. The drug, formerly known as ABBV-951,

October 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.